Please select the option that best describes you:
Topics:
Rheumatology • Pediatric Rheumatology
What additional immunomodulation would you consider in a patient with severe NXP-2+ JDM who has already received cyclophosphamide and rituximab but has persistent gastrointestinal vasculopathy?
Answer from: at Academic Institution
I'd try a JAKi.
Sign in or Register to read more